Zosano Pharma is actively seeking partnerships that utilize our proprietary transdermal microneedle patch technology.

Zosano’s delivery technology has the capability to provide a room temperature stable, transdermal product to support a wide-spread deployment of a therapeutic solution.

Partnership Opportunities: Product, Pipeline & Platform

• Zosano Product: Qtrypta for migraine and cluster headache
  Commercialization, co-promotion / marketing partnership opportunities
   
• Zosano Pipeline: Once-weekly parathyroid hormone for osteoporosis (ZP-PTH) in post-menopausal women
  Phase 1 clinical development through commercialization partnership opportunities
   
• Partner Product: Life-cycle management opportunities
  Extensive experience with 505(b)(2) regulatory pathway for patent-life extension or competitive repositioning
   
• Partner Program: Immunology / immuno-oncology research, discovery / co-development partnership opportunitie
  Cancer vaccines and Immune activation / reactivation / overriding immunological tolerance
   
• Partner Program: Prophylactic vaccines platform partnership opportunities
  Pediatric and high-value adult vaccine co-development partnerships

Zosano Pharma welcomes inquiries from companies interested in utilizing our transdermal microneedle patch with your proprietary molecule. Contact us at [email protected].